Fulcrum Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 3.77 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 287.64M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Details
| Name | Fulcrum Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 9 |
| Founded | 2015 |
| Ipo Date | 2019-07-18 |
| Ceo | Alexander Sapir |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US3596161097 |
| Cusip | 359616109 |
| Cik | 1680581 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Alexander C. Sapir | Chief Executive Officer, President and Director |
| Alan A. Musso C.M.A., CPA | Chief Financial Officer, Treasurer and Principal Accounting Officer |
| Curtis G. Oltmans J.D. | Chief Legal Officer, Head of External Affairs and Corporate Secretary |
| Dr. Bradley E. Bernstein M.D., Ph.D. | Founder |
| Dr. Michael R. Green | Founder |
| Dr. Rudolf Jaenisch M.D., Ph.D. | Founder |
| Dr. Tsun-Huei Lee M.D., Ph.D. | Founder |
| Dr. Danny Reinberg | Founder |
| Dr. Iain Fraser DPHIL | Senior Vice President of Early Development |
| Bobby Riehle Ph.D. | Head of Program Strategy and Vice President |
Contact
| Address | 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States |
| Phone | 617 651 8851 |
| Website | https://www.fulcrumtx.com |